发明名称 MARKER FOR DIAGNOSING EFFECT OF ANTICANCER AGENT
摘要 <p>The present invention enables to realize a convenient determination of a therapeutic effect of an anticancer agent on a cancer. Specifically, the present invention provides a diagnostic marker for an effect of an anticancer agent on a cancer, comprising a substance having an affinity for a fragment of an extracellular domain of c-MET; a diagnostic reagent for an effect of an anticancer agent on a cancer, comprising a substance having an affinity for a fragment of an extracellular domain of c-MET and the fragment of the extracellular domain of c-MET; and a method of testing an effect of an anticancer agent on a cancer, comprising (a) measuring a concentration of a fragment of an extracellular domain of c-MET in a biological sample from a subject, and (b) comparing the measured concentration of the fragment of the extracellular domain of c-MET with an indicator which presents a relationship between a concentration of the fragment of the extracellular domain of c-MET and the effect of the anticancer agent on the cancer.</p>
申请公布号 EP2554993(A4) 申请公布日期 2013.12.25
申请号 EP20110765360 申请日期 2011.03.18
申请人 FUJIREBIO INC. 发明人 ISE, NOBUYUKI;NAMBARA, DAISUKE;OMI, KAZUYA
分类号 G01N33/50;C07K16/28;G01N33/574 主分类号 G01N33/50
代理机构 代理人
主权项
地址